搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
Medscape
17 小时
Researchers Identify Why Some Don’t Respond to Anti-VEGF Drugs for AMD
“Expression of one HIF-regulated vasoactive gene, ANGPTL4, cooperates with VEGF to promote the development of choroidal ...
14 天
神经干细胞来源的外泌体:一种无细胞移植治疗神经疾病的潜在疗法
神经干细胞在中枢神经系统的生长发育中起着至关重要的作用,但随着神经系统疾病的发生,神经细胞的变性死亡是不可避免的。研究表明,移植的神经干细胞可以替代受损的细胞,还可以通过旁分泌作用促进神经组织再生和恢复正常功能。外泌体作为重要的旁分泌介质,不仅在物质 ...
Medscape
6 天
Management of Choroidal Neovascularization in Myopic Macular Degeneration
Choroidal neovascularization (CNV) is one of the most important vision-threatening complications secondary to pathological myopia (PM). In the last 20 years, there have been rapid advances in the ...
News Medical on MSN
13 小时
Stem-cell implants restore vision in patients with corneal stem cell deficiency
Researchers successfully tested the safety and preliminary efficacy of stem-cell-derived corneal implants, showing promise ...
Daily
1 天
Faricimab reduces fluid in Neovascular Age-Related Macular Degeneration eyes, unravels study
Age-related macular degeneration (ARMD) is the leading cause of severe vision loss in the developed world for people over 55 ...
ophthalmologytimes
6 天
FDA grants fast track status to FELIQS’ FLQ-101 for ROP
FELIQS plans to conduct a Phase 1b/2 study of FLQ-101 (tROPhy-1 study) both in the US and Japan in the first quarter of 2025.
GEN
8 天
Wet AMD Treatments Could Work Better If Both VEGF and ANGPTL4 Are Targeted
Study points to approach to improving anti-VEGF therapy for all wet AMD patients, and help subset of patients who lose vision ...
stocknews
11 天
3 Biotechnology Stocks With Promising Pipelines
With increasing chronic diseases, demand for personalized medicines, and adoption of AI, the biotech market is booming.
1 天
KALA BIO Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Ongoing patient enrollment in Phase 2b CHASE trial of KPI-012 in Persistent Corneal Epithelial Defect (PCED); topline results ...
12 天
on MSN
Porous nanofibrous microspheres show promise for diabetic wound treatment
Researchers at the Terasaki Institute for Biomedical Innovation (TIBI) have developed a revolutionary injectable granular ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果
反馈